These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31297700)

  • 1. No delayed imaging or CCK administration is needed in most cases when bowel excretion does not occur but gallbladder fills promptly.
    Choi HJ; Jacene H; Kim CK
    Ann Nucl Med; 2019 Oct; 33(10):740-745. PubMed ID: 31297700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin and morphine pharmacological intervention during 99mTc-HIDA cholescintigraphy: a rational approach.
    Krishnamurthy S; Krishnamurthy GT
    Semin Nucl Med; 1996 Jan; 26(1):16-24. PubMed ID: 8623048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed biliary-to-bowel transit in cholescintigraphy after cholecystokinin treatment.
    Kim CK; Palestro CJ; Solomon RW; Molinari DS; Lee SO; Goldsmith SJ
    Radiology; 1990 Aug; 176(2):553-6. PubMed ID: 2367674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of basal hepatic bile flow and the effects of intravenous cholecystokinin on the liver, sphincter, and gallbladder in patients with sphincter of Oddi spasm.
    Krishnamurthy GT; Krishnamurthy S; Watson RD
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):85-93. PubMed ID: 14574515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "liver scan" appearance in cholescintigraphy. A sign of complete common bile duct obstruction.
    Noel AW; Velchik MG; Alavi A
    Clin Nucl Med; 1985 Apr; 10(4):264-9. PubMed ID: 3888476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of 99Tcm-HIDA with cholecystokinin and gallbladder ejection fraction in acalculous gallbladder disease.
    Middleton GW; Williams JH
    Nucl Med Commun; 2001 Jun; 22(6):657-61. PubMed ID: 11403177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin cholescintigraphic findings in the cystic duct syndrome.
    Fink-Bennett D; DeRidder P; Kolozsi W; Gordon R; Rapp J
    J Nucl Med; 1985 Oct; 26(10):1123-8. PubMed ID: 4045555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sequential administration of an opioid and cholecystokinin on gallbladder ejection fraction: brief communication.
    Krishnamurthy S; Krishnamurthy GT
    J Nucl Med; 2006 Sep; 47(9):1463-6. PubMed ID: 16954554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cholecystokinetic agents in 99mTc-IDA cholescintigraphy.
    Freeman LM; Sugarman LA; Weissmann HS
    Semin Nucl Med; 1981 Jul; 11(3):186-93. PubMed ID: 6269216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filling, postcholecystokinin emptying, and refilling of normal gallbladder: effects of two different doses of CCK on refilling: concise communication.
    Mesgarzadeh M; Krishnamurthy GT; Bobba VR; Langrell K
    J Nucl Med; 1983 Aug; 24(8):666-71. PubMed ID: 6308188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallbladder filling and response to cholecystokinin are not affected by vagotomy.
    Pellegrini CA; Lewin M; Patti MG; Thomas MJ; Ryan T; Way LW
    Surgery; 1985 Sep; 98(3):452-8. PubMed ID: 4035567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m-IDA gallbladder kinetics and response to CCK in chronic cholecystitis.
    Raymond F; Lepanto L; Rosenthall L; Fried GM
    Eur J Nucl Med; 1988; 14(7-8):378-81. PubMed ID: 3181187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Hepatobiliary Localization of Tc-99m EC in Diuretic Renography.
    Singh D; Jain S; Jain A; Jain S
    World J Nucl Med; 2024 Jun; 23(2):88-94. PubMed ID: 38933062
    [No Abstract]   [Full Text] [Related]  

  • 14. Disorders of gallbladder function related to duodenogastric reflux in technetium-99m DISIDA hepatobiliary scintigraphy.
    Shih WJ; Coupal JJ; Domstad PA; Ram MD; DeLand FH
    Clin Nucl Med; 1987 Nov; 12(11):857-60. PubMed ID: 3427858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallbladder response to a second dose of cholecystokinin during the same imaging study.
    Sostre S; Canto MI; Kalloo AN
    Eur J Nucl Med; 1992; 19(11):964-5. PubMed ID: 1425784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintigraphic Findings Beyond Ejection Fraction on Hepatobiliary Scintigraphy: Are They Correlated With Chronic Gallbladder Disease?
    Christensen CT; Peacock JG; Vroman PJ; Banks KP
    Clin Nucl Med; 2018 Oct; 43(10):721-727. PubMed ID: 30153154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative biliary dynamics: introduction of a new noninvasive scintigraphic technique.
    Krishnamurthy GT; Bobba VR; McConnell D; Turner F; Mesgarzadeh M; Kingston E
    J Nucl Med; 1983 Mar; 24(3):217-23. PubMed ID: 6827367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous measurement of gallbladder emptying with cholescintigraphy and US during infusion of physiologic doses of cholecystokinin: a comparison.
    Masclee AA; Hopman WP; Corstens FH; Rosenbusch G; Jansen JB; Lamers CB
    Radiology; 1989 Nov; 173(2):407-10. PubMed ID: 2678254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallbladder emptying following cholecystokinin and fatty meal in normal subjects.
    Fullarton GM; Meek AC; Gray HW; Bessent RG
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():45-8. PubMed ID: 2083934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biokinetics and biliary imaging parameters of four Tc-99m iminodiacetic acid derivatives in normal subjects.
    Bobba VV; Krishnamurthy GT; Kingston E; Brown PH; Eklem M; Turner FE
    Clin Nucl Med; 1983 Feb; 8(2):70-5. PubMed ID: 6825355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.